Danaher Corporation (DAP.DE)
| Previous close | 243.05 |
| Open | 244.95 |
| Bid | 243.45 x N/A |
| Ask | 245.45 x N/A |
| Day's range | 244.95 - 245.30 |
| 52-week range | 172.40 - 245.30 |
| Volume | |
| Avg. volume | 542 |
| Market cap | 181.814B |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | 48.96 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.00 (0.41%) |
| Ex-dividend date | 28 Jun 2024 |
| 1y target est | N/A |
- PR Newswire
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
Danaher Corporation (NYSE: DHR), a global science and technology innovator ("Danaher"), today launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild TBI. As part of the Danaher Beacons program, researchers at Johns Hopkins University will leverage technology from Beckman Coulter Diagnostics, a Danaher subsidiary and leader in clinical diagnostics, to potentially establish correlations between a new biomarker panel and clinical outcomes.
- PR Newswire
Danaher to Present at Bank of America Securities Healthcare Conference
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 14, 2024 at 10:40 a.m. PT. The event will be simultaneously webcast on www.danaher.com.
- PR Newswire
Danaher Announces Quarterly Dividend
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on July 26, 2024 to holders of record on June 28, 2024.
